| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 07/03/2003 | US20030124656 Protein having glutaminase activity and gene encoding the same |
| 07/03/2003 | US20030124653 Preparing preferential enzymatic polypeptide; lysosomal hydrolases; phosphotransferases; lysosomal storage disease; translation inhibit; enzyme replacement therapy |
| 07/03/2003 | US20030124652 Methods of producing high mannose glycoproteins in complex carbohydrate deficient cells |
| 07/03/2003 | US20030124650 Isolating streptomyces serine proteases using immunoaffinity chromatography; oligopeptides |
| 07/03/2003 | US20030124645 Practical in vitro sialylation of recombinant glycoproteins |
| 07/03/2003 | US20030124642 Inhibition of 5-Aminolevulinate synthase gene expression in fungi results in no signs of successful infection or lesions. 5-Aminolevulinate synthase can be used as a target for the identification of antibiotics, preferably antifungals. |
| 07/03/2003 | US20030124613 Epitope testing using soluble HLA |
| 07/03/2003 | US20030124607 Methods related to streptomyces avermitilis gene directing the ratio of B2:B1 avermectins |
| 07/03/2003 | US20030124601 Oligonucleotide hybridizable with given gene regions; primers; measuring fluorescence |
| 07/03/2003 | US20030124598 PGC-1beta, a novel PGC-1 homologue and uses therefor |
| 07/03/2003 | US20030124587 Human tyrosine-DNA phosphodiesterase variant polypeptides and methods of use therefor |
| 07/03/2003 | US20030124586 In vitro sorting method |
| 07/03/2003 | US20030124580 Lung surfactant molecules |
| 07/03/2003 | US20030124575 Dendritic cells; antigen presenting cells; g-protein coupled receptors; immunotherapy; antiinflammatory agents; antitumor agents; viricides; drug screening |
| 07/03/2003 | US20030124573 Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides |
| 07/03/2003 | US20030124559 Rna polymerases from bacteriophage phi 6-phI 14 and use thereof |
| 07/03/2003 | US20030124531 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 07/03/2003 | US20030124529 Pregnancy-associated plasma protein-A2 (PAPP-A2) |
| 07/03/2003 | US20030124515 Target amplification of nucleic acid with mutant RNA polymerase |
| 07/03/2003 | US20030124224 Continuous fluidized bed process for providing non-dusting enzyme granules with improved characteristics; fine material that escapes from the fluid bed with the off-gas is separated off and returned to the fluidised bed |
| 07/03/2003 | US20030124147 Fusion toxin comprising the toxin domain of diphtheria toxin and a urokinase-type plasminogen activator domain; killing tumor cells, especially glioblastoma cells |
| 07/03/2003 | US20030124131 Immunoconjugates of toxins directed against malignant cells |
| 07/03/2003 | US20030124126 Nucleic acid compositions encoding mammalian DGAT2 alpha and MGAT1 polypeptide products; identifying acyltransferase inhibitors; producing triglycerides |
| 07/03/2003 | US20030124113 Human apoptosis associated proteins |
| 07/03/2003 | US20030124110 Use of modified lysozyme c to prepare medicinal compositions for the treatment of some serious diseases |
| 07/03/2003 | US20030124108 Useful in wound healing, autoimmune disorders and inflammatory diseases |
| 07/03/2003 | US20030124107 PAK5-related compositions and methods |
| 07/03/2003 | US20030124106 Diagnosing, treating, or preventing disorders associated with expression of ORP. |
| 07/03/2003 | US20030124105 Programmed cell death genes and proteins |
| 07/03/2003 | US20030124096 DNA virus, which replicates via an RNA intermediate,that comprises a nucleotide mutation in a gene encoding a DNA polymerase or part thereof; particularly hepatitis B variants |
| 07/03/2003 | CA2803931A1 Methods for producing hyaluronan in a recombinant host cell |
| 07/03/2003 | CA2471373A1 Modified tridegins, their preparation and their use as transglutaminase inhibitors |
| 07/03/2003 | CA2471369A1 Glycosyl hydrolases obtained from metagenomic analysis |
| 07/03/2003 | CA2471145A1 Dna encoding novel cyclic gmp dependent protein kinases from two protozoal sources for use as chemotherapeutic targets for antiprotozoal agents |
| 07/03/2003 | CA2470776A1 Malleable protein matrix and uses thereof |
| 07/03/2003 | CA2470063A1 Parmaceutical agents and methods for tissue and vascular regeneration |
| 07/03/2003 | CA2469928A1 Nucleic acid labeling by thermoanaerobacter thermohydrosulfuricus dna polymerase i variants |
| 07/03/2003 | CA2469375A1 Maize ccoaomt2 gene polymorphism, and uses thereof to enhance plant digestibility |
| 07/03/2003 | CA2468083A1 Use of heterocyclic carboxamides to treat anemia |
| 07/03/2003 | CA2467207A1 Novel phytases and method for producing these phytases |
| 07/03/2003 | CA2465283A1 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| 07/03/2003 | CA2462587A1 Modulating insulin receptor signaling through targeting facl |
| 07/03/2003 | CA2453810A1 Mutant proteinase inhibitors and uses thereof |
| 07/03/2003 | CA2451677A1 Compositions and methods utilizing dna polymerases |
| 07/02/2003 | EP1323827A2 Method for producing optically active 2-hydroxycycloalkanecarboxylic acid ester |
| 07/02/2003 | EP1323826A1 A cell line expressing mutated human tissue - type plasminogen activator, the constructing strategy thereof and method of preparing expressed protein |
| 07/02/2003 | EP1323825A2 Recombinant plants and DNA constructs |
| 07/02/2003 | EP1323820A2 Process for facillitated recovery of heterologous proteins from bacterial cells |
| 07/02/2003 | EP1322786A1 Method of identifying putative antibiotic resistance genes |
| 07/02/2003 | EP1322775A2 Ethanol production |
| 07/02/2003 | EP1322773A2 Glyphosate tolerant wheat plant 33391 and compositions and methods for detection thereof |
| 07/02/2003 | EP1322770A2 Pear genes codifying for beta-galactosidase, pectin methylesterase, polygalacturonase, expansins and their use |
| 07/02/2003 | EP1322769A2 Protein phosphatases |
| 07/02/2003 | EP1322768A2 Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| 07/02/2003 | EP1322767A2 Methods and compositions employing a stearoyl-coa desaturase-hscd5 |
| 07/02/2003 | EP1322766A2 Method for modifying the genome of corynebacteria |
| 07/02/2003 | EP1322764A2 Method for improved production of cyanophycin and the secondary products thereof |
| 07/02/2003 | EP1322753A2 2,5-diketo-d-gluconic acid reductases and methods of use |
| 07/02/2003 | EP1322752A2 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof |
| 07/02/2003 | EP1322751A2 Glutaryl cephalosporin amidase from pseudomonas diminuta bs-203 |
| 07/02/2003 | EP1322750A2 Proteolysis targeting chimeric pharmaceutical |
| 07/02/2003 | EP1322616A2 Quinoline-(c=o)-(di-, tri- and tetrapeptide) derivatives as caspase inhibitors |
| 07/02/2003 | EP1322152A2 Transgenic mouse for targeted recombination mediated by modified cre-er |
| 07/02/2003 | EP1107662A4 Manipulation of tocopherol levels in transgenic plants |
| 07/02/2003 | EP1045632A4 A starchless variety of pisum sativum having elevated levels of sucrose |
| 07/02/2003 | EP1017845A4 Diagnostic test for alzheimer's disease |
| 07/02/2003 | EP1003376B1 Antimicrobial composition containing a haloperoxidase, a hydrogen peroxide source, a halide source and an ammonium source |
| 07/02/2003 | EP1002100B1 Method for producing and identifying new hydrolases having improved properties |
| 07/02/2003 | EP0973905B1 Plant pyruvate dehydrogenase kinase gene |
| 07/02/2003 | EP0910246A4 Use of mutant alkyltransferases for gene therapy to protect from toxicity of therapeutic alkylating agents |
| 07/02/2003 | EP0616644B1 Fatty acid desaturase genes from plants |
| 07/02/2003 | CN1427740A Fluid bed process for production of enzyme granules |
| 07/02/2003 | CN1427078A Transglutaminase gene of Ladaka streptothrix and its coded transglutaminase |
| 07/02/2003 | CN1427077A Preparation method of angiotensin converting enzyme inhibitor affinity column medium |
| 07/02/2003 | CN1113143C Vibration damping structure with integrated elastoplastic/viscoelastic damper |
| 07/02/2003 | CN1113100C Enzymatic process for mfg. ascorbic acid, 2-keto-L-gulonic acid and esters of 2-keto-L-gulonic acid |
| 07/02/2003 | CN1113098C Process for extracting detoxicating enzyme for aflatoxin B1 |
| 07/02/2003 | CN1113094C Trehalose phosphorylase plesiomonas strain, enzyme therefrom and enzyme producing method and use |
| 07/02/2003 | CN1113093C Use of acetyl lactic decarboxylase derivatives |
| 07/02/2003 | CN1113089C Liquid tetergents containing proteolytic enzyme and protease inhibitors |
| 07/02/2003 | CN1113088C Liquid detergents containing proteolytic enzyme and proptease inhibitors |
| 07/02/2003 | CN1112855C Process for stabilizing proteins in acidic environment with high-ester pectin |
| 07/01/2003 | USH2071 Streptococcus pneumoniae gene HI0454 |
| 07/01/2003 | USH2070 Streptococcus pneumoniae gene sequence for DNA ligase |
| 07/01/2003 | US6587805 Testing a write transducer as a reader |
| 07/01/2003 | US6586661 Regulation of quinolate phosphoribosyl transferase expression by transformation with a tobacco quinolate phosphoribosyl transferase nucleic acid |
| 07/01/2003 | US6586583 Recombinant DNA molecule comprising regulatory sequence in combination with a heterologous plant promoter and structural gene; use in pulp and paper bleaching, waste destruction, soil remediation, organic synthesis |
| 07/01/2003 | US6586578 Deformylase (def1); isolated polynucleotide of given sequence; detects Staphylococcus aureus; can use to screen for antibiotics |
| 07/01/2003 | US6586574 Lyophilized composition comprising a protein and glycylglycine as a bulking agent; optionally in combination with a sugar, sugar alcohol, and/or an amino acid |
| 07/01/2003 | US6586571 Isolated polypeptide that binds to MORT-1 (mediators of receptor toxicity) protein |
| 07/01/2003 | US6586466 Carbohydrazide-protease inhibitors |
| 07/01/2003 | US6586397 Polypeptides encoding tyrosine kinase containing immunoglobulin and endithelial growth factor homology domains; induce vascularization |
| 07/01/2003 | US6586252 Nucleic acid molecule encoding the catalytic subunit of a protein phosphatase 2A that regulates flowering time in plants |
| 07/01/2003 | US6586242 TAO protein kinases and methods of use therefor |
| 07/01/2003 | US6586230 Human kinase and polynucleotides encoding the same |
| 07/01/2003 | US6586225 Nucleotide sequence coding enzymatic polypeptide; for use in the prevention of and treatment of nervous system and autoimmune disorders; for treatment of infections, alopecia and aging |
| 07/01/2003 | US6586224 Decreased immunogenicity; use in cleaning and personal care compositions |
| 07/01/2003 | US6586223 Subtilisin protease variants having amino acid substitutions in defined epitope regions |
| 07/01/2003 | US6586222 Recombinant PR-3 and compositions thereof |
| 07/01/2003 | US6586221 Carbonyl hydrolase variants derived from the DNA sequences of naturally-occurring or recombinant non-human carbonyl hydrolases are disclosed. The variant carbonyl hydrolases, in general, are obtained by in vitro modification of a precursor |